Stocktoria
INTENSITY THERAPEUTICS, INC. INTS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-06-30
INTENSITY THERAPEUTICS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| BENDER LEWIS H | President and CEO | 2026-03-26 | Grant | 37,749 | $6.11 |
| Wesolowski John M | Principal Accounting Officer | 2025-12-31 | Grant | 8,918 | $0.26 |
| Talamo Joseph | Chief Financial Officer | 2025-12-31 | Grant | 14,482 | $0.26 |
| Wesolowski John M | Principal Accounting Officer | 2025-06-30 | Grant | 69,745 | $0.26 |
| Talamo Joseph | Chief Financial Officer | 2025-06-30 | Grant | 14,179 | $0.26 |
Source: SEC EDGAR filings · CIK 0001567264 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.